The U.S. Food and Drug Administration (FDA) approved Soliris (eculizumab), the first product for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare type of blood disorder that can lead to disability and premature death. Soliris is classified as an Orphan Drug and is a new molecular entity containing an ingredient not previously marketed in the United States.
Patients in Liverpool are to trial a new therapy for pancreatic cancer — a disease which sees most sufferers die within a year of diagnosis.
Scientists have discovered a new type of cell that appears to play a role in the development of cancer ? a highly volatile, precancerous stem cell that can either remain benign or become malignant, depending upon environmental cues.
Advances in radiation therapy for cancer have made it possible to fine-tune radiation beams so they match the shape and position of a patient’s tumor nearly anywhere in the body.
A protein known as the “master watchman of the genome” for its ability to guard against cancer-causing DNA damage has been found to provide an entirely different level of cancer protection: By prompting the skin to tan in response to ultraviolet light from the sun, it deters the development of melanoma skin cancer, the fastest-increasing form of cancer in the world.
An article published in ‘The Lancet’ by researchers from the Menzies School of Health Research (MSHR) in Darwin has revealed a breakthrough in the battle to treat Malaria ? a disease which effects 40 per cent of the worlds population.
A new study to be published in an upcoming edition of the Journal of Reproductive Medicine reveals that Pycnogenol, an antioxidant plant extract from the bark of the French maritime pine tree, significantly reduces symptoms of endometriosis by 33 percent.
Critical portions of the brain in those who are obese don’t really know they are overweight, researchers have reported in the March issue of the journal Cell Metabolism, published by Cell Press.
UCLA researchers have uncovered new clues that may explain why Graves’ disease attacks the muscle tissue behind the eyes, often causing them to bulge painfully from their sockets, as in the case of the late actor Marty Feldman.
A treatment for polycystic kidney disease (PKD), a leading cause of fatal kidney failure worldwide, has been identified by a research team led by Yale biochemist Craig Crews, according to a report in the Proceedings of the National Academy of Sciences.